Vascular Biosciences announces publication of “Hemodynamic and Histologic Characterization of a Swine (Sus scrofa domestica) Model of Chronic Pulmonary Arterial Hypertension” Durnham, North Carolina, June 27, 2011 – Vascular BioSciences announces the publication of a scientific articl
Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension” Selected by Faculty of 1000 Goleta, Calif., June 24, 2011 – A recently published paper from Vascular BioSciences (VBS) in collaboration with Sanford-Burnham Medical Research Institute and the University of
VBS Pharmaceuticals announces publication of “Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension” Goleta, Calif., June 10, 2011 – VBS Pharmaceuticals, in collaboration with the Sanford-Burnham Medical Research Institute, and the University of South Alabama,
David Mann, CEO of Vascular BioSciences, Presents Opening Remarks at the Southern California Undergraduate Research Conference in Chemistry and Biochemistry (SCURC) Santa Barbara, Calif., April 24, 2011 – Opening speaker David Mann presented the following remarks at the SCURC at the U
Vascular BioSciences to Sponsor 2011 Southern California Undergraduate Research Conference in Chemistry and Biochemistry Santa Barbara, Calif., April 23, 2011 – Vascular BioSciences will be a major sponsor of the 2011 Southern California Undergraduate Research Conference in Chemistry